These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 28091333)

  • 1. An Ecological Approach to Reducing Potentially Inappropriate Medication Use: Canadian Deprescribing Network.
    Tannenbaum C; Farrell B; Shaw J; Morgan S; Trimble J; Currie J; Turner J; Rochon P; Silvius J
    Can J Aging; 2017 Mar; 36(1):97-107. PubMed ID: 28091333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deprescribing medications in older people: a narrative review.
    Salahudeen MS
    Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deprescribing in older people.
    Page AT; Potter K; Clifford R; Etherton-Beer C
    Maturitas; 2016 Sep; 91():115-34. PubMed ID: 27451330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancing the Science of Deprescribing: A Novel Comprehensive Conceptual Framework.
    Linsky A; Gellad WF; Linder JA; Friedberg MW
    J Am Geriatr Soc; 2019 Oct; 67(10):2018-2022. PubMed ID: 31430394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-dwelling older people's attitudes towards deprescribing in Canada.
    Sirois C; Ouellet N; Reeve E
    Res Social Adm Pharm; 2017; 13(4):864-870. PubMed ID: 27663392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care.
    Palagyi A; Keay L; Harper J; Potter J; Lindley RI
    BMC Geriatr; 2016 Jan; 16():15. PubMed ID: 26767619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people.
    Todd A; Jansen J; Colvin J; McLachlan AJ
    BMC Geriatr; 2018 Nov; 18(1):295. PubMed ID: 30497404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combating Polypharmacy Through Deprescribing Potentially Inappropriate Medications.
    Chou J; Tong M; Brandt NJ
    J Gerontol Nurs; 2019 Jan; 45(1):9-15. PubMed ID: 30653232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deprescribing: a new goal focused on the patient.
    Machado-Alba JE; Gaviria-Mendoza A; Machado-Duque ME; Chica L
    Expert Opin Drug Saf; 2017 Feb; 16(2):111-112. PubMed ID: 27984921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New horizons in deprescribing for older people.
    Woodford HJ; Fisher J
    Age Ageing; 2019 Nov; 48(6):768-775. PubMed ID: 31595290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process.
    Farrell B; Tsang C; Raman-Wilms L; Irving H; Conklin J; Pottie K
    PLoS One; 2015; 10(4):e0122246. PubMed ID: 25849568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
    Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM
    Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How confident are physicians in deprescribing for the elderly and what barriers prevent deprescribing?
    Djatche L; Lee S; Singer D; Hegarty SE; Lombardi M; Maio V
    J Clin Pharm Ther; 2018 Aug; 43(4):550-555. PubMed ID: 29682764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
    McIntyre C; McQuillan R; Bell C; Battistella M
    Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deprescribing: A narrative review of the evidence and practical recommendations for recognizing opportunities and taking action.
    Reeve E; Thompson W; Farrell B
    Eur J Intern Med; 2017 Mar; 38():3-11. PubMed ID: 28063660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frailty, polypharmacy and deprescribing.
    Drug Ther Bull; 2016 Jun; 54(6):69-72. PubMed ID: 27284125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Patient Preferences in Deprescribing.
    Holmes HM; Todd A
    Clin Geriatr Med; 2017 May; 33(2):165-175. PubMed ID: 28364989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of deprescribing in older adults with dementia: a narrative review.
    Sawan MJ; Moga DC; Ma MJ; Ng JC; Johnell K; Gnjidic D
    Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1367-1382. PubMed ID: 34311630
    [No Abstract]   [Full Text] [Related]  

  • 19. A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.
    Reeve E; Moriarty F; Nahas R; Turner JP; Kouladjian O'Donnell L; Hilmer SN
    Expert Opin Drug Saf; 2018 Jan; 17(1):39-49. PubMed ID: 29072544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stakeholder Perspectives on Factors Related to Deprescribing Potentially Inappropriate Medications in Older Adults Receiving Dialysis.
    Hall RK; Rutledge J; Lucas A; Liu CK; Clair Russell JS; Peter WS; Fish LJ; Colón-Emeric C
    Clin J Am Soc Nephrol; 2023 Oct; 18(10):1310-1320. PubMed ID: 37499693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.